The antibiotic erythromycin -- used to treat a wide variety of bacterial infections, such as respiratory tract infections, middle ear infections, and skin infections -- was created by Filipino scientist Abelardo Aguilar, and has earned American drug giant Eli Lilly billions of dollars. Neither Aguilar nor the Philippine government received royalties.